Published in Neuroscience on January 01, 2002
Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci (2014) 1.08
Development-based compartmentalization of the Drosophila central brain. J Comp Neurol (2010) 1.07
Extracellular matrix abnormalities in schizophrenia. Neuropharmacology (2011) 1.04
Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited. J Neurosci Res (2009) 0.91
NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurol (2009) 0.87
Role of glial cells in axonal regeneration. Exp Neurobiol (2013) 0.84
IT delivery of ChABC modulates NG2 and promotes GAP-43 axonal regrowth after spinal cord injury. Cell Mol Neurobiol (2011) 0.83
Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro. Exp Neurol (2013) 0.82
Corneal sulfated glycosaminoglycans and their effects on trigeminal nerve growth cone behavior in vitro: roles for ECM in cornea innervation. Invest Ophthalmol Vis Sci (2012) 0.82
Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration. Tissue Eng Part A (2013) 0.81
Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar. Biotechnol Bioeng (2012) 0.75
Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury. PLoS One (2017) 0.75
Carbon and electron flow in mud and sandflat intertidal sediments at delaware inlet, nelson, new zealand. Appl Environ Microbiol (1980) 4.84
The glial scar and central nervous system repair. Brain Res Bull (1999) 4.80
Regressive events in neurogenesis. Science (1984) 3.24
The oligodendrocyte precursor cell in health and disease. Trends Neurosci (2001) 2.68
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28
Changes in proportions of acetate and carbon dioxide used as methane precursors during the anaerobic digestion of bovine waste. Appl Environ Microbiol (1978) 2.26
Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci (2001) 1.99
Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci (2000) 1.95
Role of sulfate reduction versus methanogenesis in terminal carbon flow in polluted intertidal sediment of waimea inlet, nelson, new zealand. Appl Environ Microbiol (1981) 1.91
Effect of inorganic sulfide on the growth and metabolism of Methanosarcina barkeri strain DM. Appl Environ Microbiol (1979) 1.84
Production and regulation of cellulase by two strains of the rumen anaerobic fungus Neocallimastix frontalis. Appl Environ Microbiol (1985) 1.74
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord (2006) 1.51
The migration of neural crest cells and the growth of motor axons through the rostral half of the chick somite. J Embryol Exp Morphol (1985) 1.45
Fermentation of Cellulose to Methane and Carbon Dioxide by a Rumen Anaerobic Fungus in a Triculture with Methanobrevibacter sp. Strain RA1 and Methanosarcina barkeri. Appl Environ Microbiol (1982) 1.44
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord (2006) 1.39
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? J Anat (2004) 1.39
The responses of oligodendrocyte precursor cells, astrocytes and microglia to a cortical stab injury, in the brain. Neuroscience (2004) 1.28
The astrocyte/meningeal cell interface--a barrier to successful nerve regeneration? Cell Tissue Res (2001) 1.25
Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res (2002) 1.24
Targeting the neural extracellular matrix in neurological disorders. Neuroscience (2013) 1.18
Chondroitin sulfate: a key molecule in the brain matrix. Int J Biochem Cell Biol (2012) 1.18
Topographic targeting errors in the retinocollicular projection and their elimination by selective ganglion cell death. J Neurosci (1986) 1.16
Role of catabolite regulatory mechanisms in control of carbohydrate utilization by the rumen anaerobic fungus Neocallimastix frontalis. Appl Environ Microbiol (1983) 1.15
Formation of topographic maps. Annu Rev Neurosci (1988) 1.14
Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci (1999) 1.14
The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines. Neuroscience (2006) 1.13
Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord (2010) 1.12
An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci (1994) 1.09
Partitioning effects during terminal carbon and electron flow in sediments of a low-salinity meltwater pond near Bratina Island, McMurdo Ice Shelf, Antarctica. Appl Environ Microbiol (1999) 1.05
Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury. Spinal Cord (2010) 1.04
Altered CNS response to injury in the MRL/MpJ mouse. Neuroscience (2004) 1.03
The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol (1996) 1.01
Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur J Neurosci (2001) 1.01
Systemic lupus erythematosus associated with procainamide. Br J Clin Pract (1967) 1.01
Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem Soc Trans (2003) 0.99
Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience (1999) 0.99
Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS. Neuroscience (2003) 0.98
Rapid induction of the major embryonic alpha-tubulin mRNA, T alpha 1, during nerve regeneration in adult rats. J Neurosci (1989) 0.97
Chondroitin sulphate proteoglycans: inhibitory components of the glial scar. Prog Brain Res (2001) 0.96
Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem J (1995) 0.96
N-Cadherin inhibits Schwann cell migration on astrocytes. Mol Cell Neurosci (1999) 0.95
Muscle basal lamina: a new graft material for peripheral nerve repair. J Neurosurg (1986) 0.95
Dopamine cells in nigral grafts differentiate prior to implantation. Eur J Neurosci (1999) 0.94
Oxidation of Lignin-Related Aromatic Alcohols by Cell Suspensions of Methylosinus trichosporium. Appl Environ Microbiol (1990) 0.93
Interactions between meningeal cells and astrocytes in vivo and in vitro. Brain Res Dev Brain Res (1991) 0.93
Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci (1995) 0.93
Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. Exp Neurol (2000) 0.91
Isolation of a large aggregating proteoglycan from human brain. J Biol Chem (1992) 0.91
Increased survival of rat EGF-generated CNS precursor cells using B27 supplemented medium. Exp Brain Res (1995) 0.91
N-cadherin is involved in axon-oligodendrocyte contact and myelination. Mol Cell Neurosci (2001) 0.90
GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport (1996) 0.89
Activity and the control of ganglion cell death in the rat retina. Proc Natl Acad Sci U S A (1984) 0.89
Production of xylanase by the ruminal anaerobic fungus Neocallimastix frontalis. Appl Environ Microbiol (1989) 0.88
The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. Brain Res Mol Brain Res (2004) 0.88
The role of Schwann cells in the regeneration of peripheral nerve axons through muscle basal lamina grafts. Exp Neurol (1991) 0.88
Production of alpha-Amylase by the Ruminal Anaerobic Fungus Neocallimastix frontalis. Appl Environ Microbiol (1988) 0.86
Improving RPE adhesion to Bruch's membrane. Eye (Lond) (2009) 0.85
Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth. Eur J Neurosci (1998) 0.85
Axonal regeneration. Biol Rev Camb Philos Soc (1996) 0.84
Migration of oligodendrocyte precursors on astrocytes and meningeal cells. Dev Biol (1995) 0.84
Fibre order in the normal Xenopus optic tract, near the chiasma. J Embryol Exp Morphol (1984) 0.84
Robust regeneration of CNS axons through a track depleted of CNS glia. Exp Neurol (2000) 0.83
Regulation of fibronectin alternative splicing during peripheral nerve repair. J Neurosci Res (1999) 0.83
Astrocytes promote neurogenesis from oligodendrocyte precursor cells. Eur J Neurosci (2006) 0.83
The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur J Neurosci (1999) 0.83
N-cadherin influences migration of oligodendrocytes on astrocyte monolayers. Mol Cell Neurosci (2000) 0.82
Proteoglycans provide neurite guidance at an astrocyte boundary. Mol Cell Neurosci (1997) 0.82
Expression of Schwann cell markers by mammalian neural crest cells in vitro. Development (1989) 0.81
Enhanced axonal regeneration following combined demyelination plus schwann cell transplantation therapy in the injured adult spinal cord. Exp Neurol (1999) 0.81
The visuotectal projections made by Xenopus 'pie slice' compound eyes. J Embryol Exp Morphol (1983) 0.81
A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience (1995) 0.81
The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res (1996) 0.80
Increased axon growth through astrocyte cell lines transfected with urokinase. Glia (1998) 0.79
Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--II. Effects on nigral transplants in vivo. Neuroscience (1993) 0.79
A device for the implantation of multiple cellular deposits into a large volume of brain from a single cannula site. Exp Neurol (1996) 0.79
Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat. Neuroscience (1996) 0.78
Bridge grafts of fibroblast growth factor-4-secreting schwannoma cells promote functional axonal regeneration in the nigrostriatal pathway of the adult rat. Neuroscience (1996) 0.78
How axons grow down the Xenopus optic nerve. J Embryol Exp Morphol (1981) 0.78
Use of an implanted sacral nerve stimulator to restore urine voiding in chronically paraplegic dogs. J Vet Intern Med (2012) 0.77
Mitogenic effect of basic fibroblast growth factor on embryonic ventral mesencephalic dopaminergic neurone precursors. Brain Res Dev Brain Res (1993) 0.77
The effect of intraocular tetrodotoxin on the postnatal reduction in the numbers of optic nerve axons in the rat. Brain Res (1986) 0.77
Regeneration in the mammalian optic nerve. Restor Neurol Neurosci (2001) 0.77
Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro. Neuroscience (1993) 0.77
Growth-cone collapse: too much of a good thing? Trends Neurosci (1993) 0.76
A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant (1997) 0.76
Astrocyte influences on oligodendrocyte progenitor migration. Prog Brain Res (2001) 0.76
Prescription of diuretic drugs and monitoring of long-term use in one general practice. Br J Gen Pract (1992) 0.75
Addition of fresh blood to intrastriatal grafts of embryonic mesencephalon into the hemiparkinsonian rat does not impair the survival of grafted dopaminergic neurones. Exp Neurol (1999) 0.75
Factors guiding regenerating retinotectal fibres in the frog Xenopus laevis. J Embryol Exp Morphol (1985) 0.75
On the formation of eye dominance stripes and patches in the doubly-innervated optic tectum of the chick. Brain Res (1985) 0.75
Inhibition of the methylcoenzyme M methylreductase system by NAD+ and NADP+ in cell-extracts of Methanosarcina barkeri. Biochem Biophys Res Commun (1984) 0.75
Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery. Neuroreport (1999) 0.75
NMDA receptor blockade alters the topography of naturally occurring ganglion cell death in the rat retina. Dev Biol (1993) 0.75
A bacteriolytic muramidase from the basidiomycete Schizophyllum commune. J Gen Microbiol (1990) 0.75